The Translational Science Benefit Model (TSBM) is a model developed to evaluate the public health impact of scientific activities, originally developed by the Institute of Clinical and Translational Sciences (ICTS) at Washington University in St. Louis. New research led by the University of Washington (UW) Harborview Injury Prevention & Research Center (HIPRC) presents a novel process using the TSBM adapted with a modified Eisenhower matrix. The process and model were successful in engaging community stakeholders and prioritizing next steps or “translational benefits”.
This study identified direct stakeholder education on Return to Learn (RTL) and efforts to develop policy around RTL to be the highest priority in terms of future translational efforts.
“I am excited that the presented workflow could be used by other researchers to involve community stakeholders in the decision-making process about where to take their translational efforts to best realize benefits to public health and society,” said researcher Julian Takagi-Stewart.
The study was published January 2023 in Health Promotion Practice, read the full abstract here > >.
Authors on this publication represented UW School of Medicine, School of Anesthesiology and Pain Medicine, Department of Psychiatry & Behavioral Sciences; Drexel University College of Medicine; Brown School, Washington University, MO.